207 related articles for article (PubMed ID: 33865219)
21. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of autografting persons with multiple sclerosis are better in those not exposed to prior disease-modifying therapies.
Sánchez-Bonilla D; Robles-Nasta M; Gallardo-Pérez MM; Hernández-Flores EJ; Montes-Robles M; Pastelín-Martínez ML; Garcés-Eisele SJ; Olivares-Gazca JC; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Mult Scler Relat Disord; 2023 Jul; 75():104744. PubMed ID: 37178580
[TBL] [Abstract][Full Text] [Related]
23. Patients' expectations of autologous hematopoietic stem cell transplantation as a treatment for MS.
De Kleermaeker FGCM; Uitdehaag BMJ; van Oosten BW
Mult Scler Relat Disord; 2020 Jan; 37():101467. PubMed ID: 31678857
[TBL] [Abstract][Full Text] [Related]
24. Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience.
Jespersen F; Petersen SL; Andersen P; Sellebjerg F; Magyari M; Sørensen PS; Blinkenberg M
Mult Scler Relat Disord; 2023 Aug; 76():104829. PubMed ID: 37364374
[TBL] [Abstract][Full Text] [Related]
25. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
Massey JC; Sutton IJ; Ma DDF; Moore JJ
Front Immunol; 2018; 9():410. PubMed ID: 29593711
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
[TBL] [Abstract][Full Text] [Related]
27. Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
Tolf A; Gauffin H; Burman J; Landtblom AM; Flensner G
PLoS One; 2024; 19(2):e0297573. PubMed ID: 38324607
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis.
Mariottini A; Innocenti C; Forci B; Magnani E; Mechi C; Barilaro A; Nistri R; Fani A; Saccardi R; Massacesi L; Repice AM
Eur J Neurol; 2019 Apr; 26(4):624-630. PubMed ID: 30414315
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Dinner G; Maceski A; Berenjeno-Correa E; Müller AM; Jelcic I; Kuhle J; Martin R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142860
[TBL] [Abstract][Full Text] [Related]
30. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis.
Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DD; Moore JJ; Massey JC
Mult Scler; 2021 Nov; 27(13):2112-2115. PubMed ID: 33870788
[TBL] [Abstract][Full Text] [Related]
32. Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Zafeiri L; Åkerfeldt T; Tolf A; Carlson K; Skalkidou A; Burman J
PLoS One; 2023; 18(4):e0284288. PubMed ID: 37043510
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
Mehra V; Rhone E; Widya S; Zuckerman M; Potter V; Raj K; Kulasekararaj A; McLornan D; de Lavallade H; Benson-Quarm N; Lim C; Ware S; Sudhanva M; Malik O; Nicholas R; Muraro PA; Marsh J; Mufti GJ; Silber E; Pagliuca A; Kazmi MA
Clin Infect Dis; 2019 Oct; 69(10):1757-1763. PubMed ID: 30980715
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation.
Pavlovic I; Zjukovskaja C; Nazir FH; Müller M; Wiberg A; Burman J
Mult Scler Relat Disord; 2024 Apr; 84():105482. PubMed ID: 38341978
[TBL] [Abstract][Full Text] [Related]
35. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.
Saiz A; Carreras E; Berenguer J; Yagüe J; Martínez C; Marín P; Rovira M; Pujol T; Arbizu T; Graus F
Neurology; 2001 Apr; 56(8):1084-9. PubMed ID: 11320183
[TBL] [Abstract][Full Text] [Related]
36. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.
Miller AE; Chitnis T; Cohen BA; Costello K; Sicotte NL; Stacom R;
JAMA Neurol; 2021 Feb; 78(2):241-246. PubMed ID: 33104165
[TBL] [Abstract][Full Text] [Related]
37. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.
Muraro PA; Martin R; Mancardi GL; Nicholas R; Sormani MP; Saccardi R
Nat Rev Neurol; 2017 Jul; 13(7):391-405. PubMed ID: 28621766
[TBL] [Abstract][Full Text] [Related]
38. Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series.
Nicholas RS; Rhone EE; Mariottini A; Silber E; Malik O; Singh-Curry V; Turner B; Scalfari A; Ciccarelli O; Sormani MP; Olavarria E; Mehra V; Gabriel I; Kazmi MA; Muraro P;
Neurology; 2021 Aug; 97(9):e890-e901. PubMed ID: 34253634
[TBL] [Abstract][Full Text] [Related]
39. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis.
Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kartashov AV; Kurbatova KA; Gorodokin GI; Novik AA
Exp Hematol; 2012 Nov; 40(11):892-8. PubMed ID: 22771495
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis.
Ge F; Lin H; Li Z; Chang T
Neurol Sci; 2019 Mar; 40(3):479-487. PubMed ID: 30535563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
